The Established Investigator Grant from the National Scleroderma Foundation funds innovative pilot studies to advance scientific understanding and treatment of scleroderma.
Funder: National Scleroderma Foundation
Due Dates: September 15, 2026: Full application submission deadline (Established Investigator Grant, FY27 cycle)
Funding Amounts: Up to $200,000 total over two years ($100,000/year including indirect costs; 8% max for indirects)
Summary: Supports established researchers conducting innovative pilot studies in scleroderma to generate data for future, larger research projects.
The Established Investigator Grant from the National Scleroderma Foundation provides funding to support established researchers pursuing highly innovative or highly relevant pilot studies in scleroderma research. The grant is intended to enable investigators to generate preliminary data that can lead to more substantial research grants from federal or non-federal sources. Projects may address a wide range of topics related to scleroderma, including but not limited to disease mechanisms, therapeutic development, clinical manifestations, and health services research. The program is open to both investigators within and outside the scleroderma field and encourages proposals likely to advance the scientific understanding and treatment of scleroderma.